The dosage may vary depending on the severity of deficiency, medical condition, and response to treatment
The Sjgrens syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production
Presented for research literature review only Montaine F et al
BPC-157 accelerates tissue repair while TB-500 reduces inflammation and enhances cellular migration, creating optimal conditions for healing
Does not interact with known drug-metabolising enzymes, which reduces the probability of drug-drug interactions, but long-term metabolic consequences of sustained NNMT suppression in humans remain uncharacterised
This work was supported by the Swedish Research Council Postdoc FellowshipC0657401 (to LJ), Stanford University Medical Scholars Research Program, Howard Hughes Medical Institute Medical Fellows Program (to GSK) and NIH/NIDCD K08DC011043, RO1DC01910, Department of Defense W81XWH-14-1-0517, Akiko Yamazaki and Jerry Yang Faculty Scholar Fund, and California Initiative in Regenerative MedicineRN3-06529 (to AGC)